Boston Partners Long/Short Research Fund Institutional Class BPIRX

Medalist Rating as of | See Boston Partners Investment Hub
  • NAV / 1-Day Return 14.72  /  +0.34 %
  • Total Assets 599.8M
  • Adj. Expense Ratio
    1.410%
  • Expense Ratio 1.920%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Long-Short Equity
  • Investment Style Mid Value
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield 0.92%
  • Turnover 65%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0

Morningstar’s Analysis BPIRX

Will BPIRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Boston Partners Long/Short Rsrch Instl holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BPIRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 10.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Asset Offset

18.76 110M
—

Cash And Cash Equivalents

18.55 109M
Cash and Equivalents

Cash Offset

13.56 80M
—

Flex Ltd

1.90 11M
Technology

Seagate Technology Holdings PLC

1.47 9M
Technology

Frontdoor Inc

1.40 8M
Consumer Cyclical

JPMorgan Chase & Co

1.27 7M
Financial Services

AbbVie Inc

1.09 6M
Healthcare

Wells Fargo & Co

1.09 6M
Financial Services

UnitedHealth Group Inc

1.03 6M
Healthcare

Sponsor Center